{
    "nct_id": "NCT04561765",
    "official_title": "Innovation in the Treatment of Persistent Pain in Adults With Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope Mobile Application- Clinical Trial",
    "inclusion_criteria": "* adults 18+\n* able to read and understand English at 5th grade level\n* permanently reside in the United States\n* have pain interference aggregate scores of three or more in the last two weeks using the Brief Pain Inventory-Short Form (BPI-SF) scale\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 72 Years",
    "exclusion_criteria": "* have an undiagnosed case of NF1\n* have documented major co-occurring psychiatric disease\n* have moderate to severe cognitive deficits\n* have depression assessed using the Patient Health Questionnaire (PHQ-9) or anxiety assessed using the Generalized Anxiety Disorder scale (GAD-7) greater than or equal to the appropriate thresholds (10=mild major depression; 5=mild severe anxiety)",
    "miscellaneous_criteria": ""
}